View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
1218-0184
ICR Reference No:
201303-1218-001
Status:
Historical Active
Previous ICR Reference No:
201108-1218-006
Agency/Subagency:
DOL/OSHA
Agency Tracking No:
1218-0184(2013)
Title:
4,4'-Methylenedianiline (MDA) for General Industry (29 CFR 1910.1050)
Type of Information Collection:
Extension without change of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
06/10/2013
Retrieve Notice of Action (NOA)
Date Received in OIRA:
04/23/2013
Terms of Clearance:
Inventory as of this Action
Requested
Previously Approved
Expiration Date
06/30/2016
36 Months From Approved
06/30/2013
Responses
659
0
577
Time Burden (Hours)
370
0
297
Cost Burden (Dollars)
27,982
0
21,416
Abstract:
The purpose of this Standard and its information collection requirements is to provide protection for workers from adverse health effects associated with occupational exposure to Methylenedianiline (MDA) in General Industry. Employers must monitor worker exposures within the permissible exposure limits, provide workers with medical examinations and training, and establish and maintain worker exposure-monitoring and medical records.
Authorizing Statute(s):
US Code:
29 USC 651
Name of Law: The Occupational Safety and Health Act
US Code:
29 USC 657
Name of Law: The Occupational Safety and Health Act
US Code:
29 USC 655
Name of Law: The Occupational Safety and Health Act
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
78 FR 6350
01/30/2013
30-day Notice:
Federal Register Citation:
Citation Date:
78 FR 23785
04/22/2013
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
1
IC Title
Form No.
Form Name
4,4'-Methylenedianiline (MDA) for General Industry (29 CFR 1910.1050)
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
659
577
0
0
82
0
Annual Time Burden (Hours)
370
297
0
0
73
0
Annual Cost Burden (Dollars)
27,982
21,416
0
0
6,566
0
Burden increases because of Program Change due to Agency Discretion:
No
Burden Increase Due to:
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
The Agency is requesting an adjustment increase of 73 burden hours from 297 to 370 hours. The adjustment is the result of increasing the job hire rate from 10% to 25.6%, resulting in an increased number of workers: receiving initial medical examinations, being trained, receiving exposure monitoring training, and requesting access to records. Also, this adjustment occurred because of the increase in the methods of compliance hours section. There is an overall adjustment increase in capital costs $6,566 (from $21,416 to $27, 982) resulting from an increase in the number of workers receiving medical examinations and, the cost of a medical examinations increasing from $168 to $187. In addition, the total cost of exposure monitoring increased as a result of more workers being covered by the exposure monitoring provisions and an increase in the cost of laboratory analysis from $107 to $119.
Annual Cost to Federal Government:
$38
Does this IC contain surveys, censuses, or employ statistical methods?
No
Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002?
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
Uncollected
Agency Contact:
Robert Washington 202 693-2259 Washington.Robert@dol.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
04/23/2013